Cold Spring Harbor Laboratory  
Contact Us | Faculty & Staff Directory

Harbor Transcript


Contact Public Affairs

We want to hear from you.
Contact Us

Follow us on

  facebook-icon twitter-icon instagram-icon3 youtube-icon 

  wordpress-icon2 rss-icon email-icon linkedin-icon


candidate drug BI 7273
A collaborative effort by cancer researchers at Cold Spring Harbor Laboratory (CSHL) and chemists at Boehringer Ingelheim (BI), a pharmaceutical firm, has resulted in the identification of a new drug target in leukemia and creation of a candidate drug that hits the target. Perhaps even more important, the research demonstrates a new, highly accurate way of proving how this and certain other classes of drugs work -- extremely valuable information in the risky business of drug development. Read more

CSHL in the News

The Scientist
Two steps toward establishing priority of discovery
July 19, 2016

The New York Times
Zika data from the lab, and right to the web
July 18, 2016

International Business Times

Mapping the brain
July 14, 2016

Hope for better ovarian cancer drugs
July 14, 2016

Brain data goldmine could reveal how neurons compute
July 13, 2016

Innovate LI
Precision medicine...


  Latest News